Ning, Jing
3 papers on CoChatORCID 0009-0005-3785-6923
Most cited papers
- Verified
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Ji, L., Gao, L., Xue, H., Tian, J., Wang, K., Jiang, H., Huang, C., Lian, Q., Yuan, M., Gao, G., et al. (2025) · The Lancet Diabetes & Endocrinology
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 35
- Verified
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
Zhu, D., Wang, W., Tong, G., Ma, G., Ma, J., Han, J., Zhang, X., Liu, Y., Gan, S., Qin, H., et al. (2024) · Nature Communications
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 34
- Verified
HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
Ning, J., Yang, R., Wang, H., & Cui, L. (2021) · Experimental and Therapeutic Medicine
Multiple Myeloma Research and TreatmentsAdvanced Glycation End Products research
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free